Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders

NCT02339402 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2017-01-13

No results posted yet for this study

Summary

Developing a new non-invasive prenatal test for single gene disorders from cell free fetal DNA, retrieved from the mothers blood.

Conditions

  • Hereditary Disease

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER
  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Christine de Die, MD PhD · Maastricht UMC

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2018-01-31
Completion
2018-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339402 on ClinicalTrials.gov